Hypomethylating agent provided as intravenous formulation for myelodysplastic syndromes and acute myeloid leukemia. Applied in hematology departments of medical facilities and cancer institutes. Suppliers deliver to hospital pharmacies and oncology specialists via B2B pharmaceutical channels.